Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product

Eculizumab (Soliris)

Soliris is used to prevent the breakdown of red blood cells in people with paroxysmal nocturnal hemoglobinuria (PNH).
Soliris is also used to treat a rare chronic blood disease called atypical hemolytic uremic syndrome (aHUS).

Trade name: ​Soliris

Manufacturer: No

Each ml contains 300mg of Eculizumab

Presentation: Solution for infusion

Strength:  300mg  

Pack Size: 1x30ml

Pack Insert: No

National Drug Code: No

Marketing Authorization Holder: Alexion Europe SAS